Peripheral Arterial Disease Trial, Recruiting (NCT04903912)

Peripheral Arterial Disease Trial, Recruiting NCT04903912 Sponsor: Federico II University Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04903912 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with peripheral artery disease (a condition where the arteries supplying blood to the limbs become narrowed or blocked), confirmed in one or more of the following ways:
People who experience leg pain when walking (called intermittent claudication), where a significant blockage or narrowing has been found in the leg arteries, or where a special blood flow test in the legs has shown an abnormal result
People who have a severe form of reduced blood flow to the limbs (called critical limb ischemia), where a significant blockage or narrowing has been found in the leg arteries, or where a special blood flow test has shown an abnormal result
People who have a narrowing of at least 50% in one of the main arteries in the neck (carotid artery)
People who have a bulge or enlargement in the main abdominal artery (aorta) of 3 cm or larger
People who have previously had a procedure to restore blood flow in the leg or neck arteries, or who have been treated for an aortic aneurysm

Who may not be able to join:

People who do not wish to sign the consent form agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390817462240

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04903912

Sponsor: Federico II University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +390817462240

More information: https://clinicaltrials.gov/study/NCT04903912

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with peripheral artery disease (a condition where the arteries supplying blood to the limbs become narrowed or blocked), confirmed in one or more of the following ways:
People who experience leg pain when walking (called intermittent claudication), where a significant blockage or narrowing has been found in the leg arteries, or where a special blood flow test in the legs has shown an abnormal result
People who have a severe form of reduced blood flow to the limbs (called critical limb ischemia), where a significant blockage or narrowing has been found in the leg arteries, or where a special blood flow test has shown an abnormal result
People who have a narrowing of at least 50% in one of the main arteries in the neck (carotid artery)
People who have a bulge or enlargement in the main abdominal artery (aorta) of 3 cm or larger
People who have previously had a procedure to restore blood flow in the leg or neck arteries, or who have been treated for an aortic aneurysm

Who may not be able to join:

People who do not wish to sign the consent form agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Federico II University

Registry

ClinicalTrials.gov

Start date

1 May 2021

Est. completion

1 May 2031

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Major Adverse Cardiovascular Events (MACE); Major Adverse Limb Events (MALE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov